Tuesday, February 5, 2019

Attn. Propecia® Plaintiffs' Lawyers: Responses Required In US DC ED NY By Valentines Day, 2019.


See the below, if you are representing any remaining finasteride claimant. Backgrounder here.

Merck has moved to keep the remaining cases, resulting from the earlier MDL, in the EDNY. If you wish to return to your home courts, on these non-settled cases, you must speak up. See the able Judge Brian Cogan's order of February 1, 2019 (in full):

. . . .The above-captioned cases relate to the multi-district litigation captioned In re: Propecia (Finasteride) Products Liability Litigation, No. 12-md-2331.

On January 4, 2019, the Court ordered the parties to show cause by January 23, 2019 why these cases should not be transferred out of the Eastern District of New York in light of the Court’s orders approving the settlement of the multi-district litigation and distribution of settlement funds. On January 23, 2019, defendants Merck & Co., Inc. and Merck Sharp & Dohme Corp. filed a response in each of the above captioned cases that opposed transferring these cases out of the Eastern District of New York.

The Court has received responses to Merck’s submissions in some but not all of the above-captioned cases. Any party who intends to respond to Merck and has not done so already must submit a response within 14 days of the entry of this order.

SO ORDERED. . . .


Now you know -- and. . . I for one will set my TV to any cable provider not airing the SOTU tonight. I want it to be counted. I did anything but listen to his lies, willingly. . . . Out.

नमस्ते

No comments: